Ubiquitination, also known as ubiquitylation, is a vital post-translational modification of proteins that play a crucial role in the multiple biological processes including cell growth, proliferation and apoptosis. K63-linked ubiquitination is one of the vital post-translational modifications of proteins that are involved in the activation of protein kinases and protein trafficking during cell survival and proliferation. It also contributes to the development of various disorders including cancer, neurodegeneration and cardiac hypertrophy. In this review, we summarize the role of K63-linked ubiquitination signalling in protein kinase activation and its implications in cardiac hypertrophy. We have also provided our perspectives on therapeutically targeting K63-linked ubiquitination in downstream effector molecules of growth factor receptors for the treatment of cardiac hypertrophy.
| INTRODUCTION
Ubiquitin (Ub) is a protein with 76-amino acids, which is a fundamental unit of ubiquitylation process ( Figure 1A ). Ubiquitination is one of the post-translational modification processes that promote proteostatic processes by covalently attaching Ub to targeted proteins and regulating their activities and levels. In this process, Ub is specifically attached to the lysine (lys; K) residues on target proteins in a precisely timed manner through a cascade enzyme systems composed of ubiquitin-activating enzyme (E1), ubiquitinconjugating enzyme (E2) and ubiquitin ligase (E3). 1 As a first step, Ub is activated by E1 in an ATP-dependent manner and it forms a complex with E1 enzyme through a thioester bond. Then, the activated Ub is transferred to the cysteine residue in the active site of E2. In the final step, E3 ligase is involved in the transfer of Ub from the E2 to a specific lysine residue of the substrate protein 2,3 ( Figure 1B ). As for phosphorylation, ubiquitination is a reversible process in which the attached Ub is removed from the target proteins by deubiquitylation enzymes (DUBs; Figure 1B ).
There are different types of Ub system-dependent post-translational modifications in proteins that diversely alter the fate of target proteins. 4 The best-studied ubiquitination is k48-linked polyubiquitination, which primarily leads to proteasomal degradation. 5 Apart from this, lysine 6-, 11-, 27-and 29-linked polyubiquitination promotes the degradation of proteins in a 26S
proteasome apparatus-dependent manner. While K63-linked ubiquitination of proteins contributes to various essential cellular activities including signal transduction, protein trafficking, proteinprotein interaction and DNA damage response. 6, 7 Recent evidence suggests that K63-linked ubiquitination is functionally important for various biological functions including cell cycle progression, immune response, autophagy and neural cell functions. [8] [9] [10] Thus, the post-translational modifications of protein by k63-linked polyubiquitination are implicated in a wide range of cellular functions.
In this review, we have focused on the role of K63-linked ubiquitination in the cardiac hypertrophy. The exploration of the indepth mechanism by which K63-linked ubiquitination regulates cell proliferation, apoptosis and survival could provide a new effective therapeutic strategy for the pathological cardiac hypertrophyassociated heart dysfunction.
| UBIQUITIN MODIFICATIONS
Ub is evolutionarily conserved across different species that specifically attaches to the lysine residues of targeted proteins through the sequential action of E1, E2 and E3 enzymes. The human genome encodes 2 E1 enzymes, about 50 E2 enzymes and more than 600 E3 ligating enzymes. 11 The ubiquitination modification occurs with spatial, temporal and substrate specificity. The E2-conjugating system determines the type of ubiquitination modification on targeted proteins, and the substrate specificity is determined by E3 enzyme.
Ub contains 7 internal lysine residues (K6, K11, K27, K29, K33, K48 and K63), which is utilized for the formation of different type of polyubiquitin chains linkage ( Figure 1C ). The vast majority of E2-conjugating enzymes trigger K48-linked ubiquitination, which is a typical signal for the proteasomal degradation of substrate proteins. 2 Cezanne and Cezanne2, the 2 known DUBs specific for Lys11-linked polyUb, regulate the NF-jB signalling and inflammation. 33 On the other hand, JAMMs, a family of DUBs with zinc metalloprotease activity, share the specificity for Lys63-linked polyubiquitin. 34, 35 The
Ub editing activity of Josephin ATXN3 is restricted specifically to K63-linked Ub chains and mixed-linkage Ub chains. 36 Given the fact that DUBs regulate the turnover rate, activation, recycling and localization of multiple proteins, they are central players in governing the signalling pathways and cell homeostasis. Due to their role in proteostasis, they have fundamental role in both normal and pathogenic cellular processes. [37] [38] [39] Most strikingly, recent evidence indicates that the dysregulation of DUB function is closely associated with several diseases, including cancer and heart diseases.
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| K63-UBIQUITINATION PLAYS AN IMPORTANT ROLE IN NF-j B ACTIVATION AND PATHOLOGICAL CARDIAC HYPERTROPHY
Heart failure is one of the leading causes of death worldwide, and cardiac hypertrophy is a major risk factor for the development of heart failure. 43, 44 Emerging evidence suggests that K63-linked ubiquitination plays a crucial role in the regulation of pathways such as NF-jB, which is implicated in the development and progression of cardiac hypertrophy. 45 NF-jB is a ubiquitous inducible transcription factor, which can activate expression of groups of genes involved in immune response, inflammation, cell survival, apoptosis or cell growth that depends on the stimuli and extracellular factors. 46 NFjB-inducing kinase (NIK), a key molecule of non-canonical NF-jB signalling pathway, phosphorylates IjB kinases (IKKs), which consist of 3 subunits namely IKKa kinase, IKKb kinase and IKKc (a regulatory subunit). The increased activity of NF-jB signalling contributes to hypertrophic responses. 47, 48 For example, the activation of NF-jB is necessary for the myotrophin-induced cardiac hypertrophy in cardiomyocytes. 49 The cardiac hypertrophic agonists such as ANG II can increase the expression and activity of NF-jB. 50 The cell surface receptors such as TNF receptor(TNFR) Many experimental studies confirmed that there is a direct relationship between TRAF6-dependent K63 polyubiquitination and activation of TAK1. In transgenic mice with cardiac-specific overexpression of TRAF6, the activity of TAK1 is increased, while it is suppressed by TRAF6 ablation, which has insignificant effects on the phosphorylation of other responders for hypertrophic stress such as TBK1, ASK1, PI3k, Ilk and Fak. It is well known that the activation of JNK1/2 and p38 is mediated by several upstream kinases in response to various hypertrophy stimuli. TRAF6 acts as an upstream activator of TAK1-JNK1/2/p38 signalling pathway, which is associated with worsening of pathological hypertrophy. In aortic banding surgical model of cardiac failure, the overexpression of TRAF6 specifically activates JNK1/2 and p38 signalling and exacerbates the pressure overload-induced hypertrophy and cardiac dysfunction. On the other hand, the silencing of TRAF6 reduces the phosphorylation F I G U R E 2 A schematic diagram of the molecular mechanisms underlying K63-linked polyubiquitination and cardiac hypertrophy. In TNF-a pathway, TNFR recruits its adaptor protein TRADD in response to binding of TNF-a. TRADD further recruits TRAF2, TRAF5 and RIP1 to the receptor complex. TRAF2/5-mediated K63 polyubiquitination of RIP1 further recruits TAB2 and TAK1 in the cytoplasm, which activates TAK1 by phosphorylation. The activated RIP1-TAK1-TAB2 complex subsequently promotes activation of MEKKs, which in turn activates the MAP kinase kinases, culminating in MAPK activation (JNK, ERK and p38), and activates p38 and JNK. These terminal kinases then proceed to phosphorylate transcription factors within the nucleus, as well as other regulatory proteins in the nucleus. And also K63 polyubiquitination chains of NEMO increases the activity of IKK complex which leads to IjBa-dependent activation of NF-jB pathway. The TNF-a pathway is regulated by deubiquitinases A20 and CYLD levels of JNK1/2 and p38 in the hypertrophied heart. 63, 64 These findings reveal that oxidative stress-induced activation of ubiquitin catenin, c-Myc and NFAT, and it also inhibits the translation initiation factor eIF2B. 69, 70 The overexpression of GSK-3b can blunt pathological hypertrophy caused by cardiac pressure overload. 70 However, the aberrant activation of AKT signalling in the hypertrophic heart suppresses activity of GSK-3b. Several reviews have covered the molecular details of K63-linked ubiquitination and its critical role in the regulation of AKT kinase activation and cardiac hypertrophy. 71, 72 In this part of review, we have focused on the regulatory function of K63-linked polyubiquitination in protein kinase activity by taking the serine/threonine kinase AKT as an example (PDK1). 69 Of the 3 AKT genes, AKT1 and AKT2 are highly expressed in the heart. AKT1 is important for the proper development and size of the heart, as evident from a reduction in heart size in mice with genetic ablation of AKT1. However, AKT2 deletion does not show any change in the heart size. 74, 75 Similarly, the cardiac-specific suppression of PI3K, an immediate upstream activator of AKT, causes reduction in the size of the heart. 76 These findings suggest that AKT signalling plays an important role in the physiological growth of the heart.
Apart from the conventional phosphorylation events, the post- F I G U R E 3 Ubiquitination regulates activation of AKT kinase. The growth factor IGF-1 triggers K63-linked ubiquitination of AKT and it promotes recruitment of AKT to membrane, which subsequently phosphorylated by PDK1 and mTOR. The activated AKT translocates to the nucleus and catalyses the transcription of genes associated with the heart growth and hypertrophy. E3 ligase TRAF6 contributes to Akt kinase activation by promoting K63-linked polyubiquitination A study in hepatic cells found that TAK1 autophosphorylation by the interaction of TRAF3-TAK1 disrupts AKT-GSK3b/FOXO1 signalling. 78 In AKT, K8 and K14 residues within the PH (pleckstrin homology) domain are major sites of ubiquitination. 79 This is evident from the remarkable reduction in ubiquitination level in AKT K8R
and AKT K14R mutants, and this mutation blocked the recruitment of AKT to the membrane sites and its phosphorylation. This study also indicated that ubiquitination-mediated AKT membrane recruitment does not result from PIP3 binding. 80 Apart from this, K14 residue within the PIP3-binding domain of AKT is required for its with PIP3, which is evident from the inability of binding of mutant (K14R) AKT with PIP3. 77, 81, 82 The expression of TRAF2, an E3 ligase, is upregulated in the failing heart and its overexpression enhances cardiac hypertrophy and ventricular dysfunction by activating AKT/GSK3b signalling. jB signalling during embryogenesis. 85 The deubiquitinating enzyme ubiquitin-specific protease 4 (USP4) attenuates major hypertrophic signalling pathways, such as TAK1-JNK and TAK1-p38, by removing the K63-linked polyubiquitination of TAK1. Thus, the increased expression of USP4 can suppress pathological cardiac hypertrophy.
However, the expression of USP4 is decreased in failing human heart as well as in experimental animals with pathological hypertrophy. 86 Similarly, CYLD prevents activation and recruitment of TAKl by cleaving the K63 polyubiquitin chain of TRAF2,TRAF6 and NEMO (Figure 2 ), which leads to inactivation of IKK and suppression of downstream of NF-jB pathway. 84, 87 Similarly, the ubiquitination of 97 A molecular study found that USP18 inactivates TAK1 by deubiquitinating K63-linked polyubiquitination and it subsequently suppresses the downstream NF-jB and JNK1/2 signalling pathways, which plays critical role in NAFLD progression. 98 USP14 also contributes to suppress the development of cardiac hypertrophy by increasing phosphorylation of GSK-3b (Table 2) . 99 Together, these findings indicate that the most of the DUBs protect the cardiac structure and function against pathological cardiac modelling caused by various stimulus.
| CONCLUSION S
The ubiquitination and deubiquitination systems have a crucial role 
